Xenon arc panretinal photocoagulation for central retinal vein occlusion

A randomized prospective study

Donald R. May, Michael Klein, Gholam A. Peyman, Motilal Raichand

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Thirty-three patients with central retinal vein occlusion were evaluated for the effects of scatter xenon arc panretinal photocoagulation. Thirty-four eyes (2 eyes of 1 patient) were randomly divided into a treatment (15 eyes) and a nontreatment group (19 eyes). The average follow-up per eye has been 29 months. The visual prognosis was not significantly better in either group. There was no difference in the development of fundus neovascularisation between groups. None of the patients in the treated group developed rubeosis or neovascular glaucoma. Two patients in the nontreatment group initially had rubeosis and 3 developed it after entry. All 5 involved eyes developed neovascular glaucoma. A significantly greater amount of central retinal capillary drop-out was present in the untreated eyes that developed rubeosis than those untreated eyes which did not. The eyes in the treated group had a similar range of capillary drop-out area, but none of these eyes developed rubeosis or neovascular glaucoma. Panretinal photocoagulation prevented the development of rubeosis and neovascular glaucoma in susceptible eyes.

Original languageEnglish (US)
Pages (from-to)725-734
Number of pages10
JournalBritish Journal of Ophthalmology
Volume63
Issue number11
DOIs
StatePublished - 1979
Externally publishedYes

Fingerprint

Retinal Vein
Retinal Vein Occlusion
Xenon
Light Coagulation
Prospective Studies
Neovascular Glaucoma

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine
  • Ophthalmology

Cite this

Xenon arc panretinal photocoagulation for central retinal vein occlusion : A randomized prospective study. / May, Donald R.; Klein, Michael; Peyman, Gholam A.; Raichand, Motilal.

In: British Journal of Ophthalmology, Vol. 63, No. 11, 1979, p. 725-734.

Research output: Contribution to journalArticle

@article{b461e8a5c4de4c028188ff043f690256,
title = "Xenon arc panretinal photocoagulation for central retinal vein occlusion: A randomized prospective study",
abstract = "Thirty-three patients with central retinal vein occlusion were evaluated for the effects of scatter xenon arc panretinal photocoagulation. Thirty-four eyes (2 eyes of 1 patient) were randomly divided into a treatment (15 eyes) and a nontreatment group (19 eyes). The average follow-up per eye has been 29 months. The visual prognosis was not significantly better in either group. There was no difference in the development of fundus neovascularisation between groups. None of the patients in the treated group developed rubeosis or neovascular glaucoma. Two patients in the nontreatment group initially had rubeosis and 3 developed it after entry. All 5 involved eyes developed neovascular glaucoma. A significantly greater amount of central retinal capillary drop-out was present in the untreated eyes that developed rubeosis than those untreated eyes which did not. The eyes in the treated group had a similar range of capillary drop-out area, but none of these eyes developed rubeosis or neovascular glaucoma. Panretinal photocoagulation prevented the development of rubeosis and neovascular glaucoma in susceptible eyes.",
author = "May, {Donald R.} and Michael Klein and Peyman, {Gholam A.} and Motilal Raichand",
year = "1979",
doi = "10.1136/bjo.63.11.725",
language = "English (US)",
volume = "63",
pages = "725--734",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Xenon arc panretinal photocoagulation for central retinal vein occlusion

T2 - A randomized prospective study

AU - May, Donald R.

AU - Klein, Michael

AU - Peyman, Gholam A.

AU - Raichand, Motilal

PY - 1979

Y1 - 1979

N2 - Thirty-three patients with central retinal vein occlusion were evaluated for the effects of scatter xenon arc panretinal photocoagulation. Thirty-four eyes (2 eyes of 1 patient) were randomly divided into a treatment (15 eyes) and a nontreatment group (19 eyes). The average follow-up per eye has been 29 months. The visual prognosis was not significantly better in either group. There was no difference in the development of fundus neovascularisation between groups. None of the patients in the treated group developed rubeosis or neovascular glaucoma. Two patients in the nontreatment group initially had rubeosis and 3 developed it after entry. All 5 involved eyes developed neovascular glaucoma. A significantly greater amount of central retinal capillary drop-out was present in the untreated eyes that developed rubeosis than those untreated eyes which did not. The eyes in the treated group had a similar range of capillary drop-out area, but none of these eyes developed rubeosis or neovascular glaucoma. Panretinal photocoagulation prevented the development of rubeosis and neovascular glaucoma in susceptible eyes.

AB - Thirty-three patients with central retinal vein occlusion were evaluated for the effects of scatter xenon arc panretinal photocoagulation. Thirty-four eyes (2 eyes of 1 patient) were randomly divided into a treatment (15 eyes) and a nontreatment group (19 eyes). The average follow-up per eye has been 29 months. The visual prognosis was not significantly better in either group. There was no difference in the development of fundus neovascularisation between groups. None of the patients in the treated group developed rubeosis or neovascular glaucoma. Two patients in the nontreatment group initially had rubeosis and 3 developed it after entry. All 5 involved eyes developed neovascular glaucoma. A significantly greater amount of central retinal capillary drop-out was present in the untreated eyes that developed rubeosis than those untreated eyes which did not. The eyes in the treated group had a similar range of capillary drop-out area, but none of these eyes developed rubeosis or neovascular glaucoma. Panretinal photocoagulation prevented the development of rubeosis and neovascular glaucoma in susceptible eyes.

UR - http://www.scopus.com/inward/record.url?scp=0018707350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018707350&partnerID=8YFLogxK

U2 - 10.1136/bjo.63.11.725

DO - 10.1136/bjo.63.11.725

M3 - Article

VL - 63

SP - 725

EP - 734

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 11

ER -